mannitol has been researched along with Multiple Sclerosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Csepregi, A; Malfertheiner, P; Neumann, H; Sailer, M | 1 |
| Bowen-Yacyshyn, MB; Meddings, J; Sadowski, D; Yacyshyn, B | 1 |
| Davis, FA; Schauf, CL; Stefoski, D | 1 |
1 trial(s) available for mannitol and Multiple Sclerosis
| Article | Year |
|---|---|
Multiple sclerosis patients have peripheral blood CD45RO+ B cells and increased intestinal permeability.
Topics: Antigens, CD20; B-Lymphocytes; Fluorescent Antibody Technique; Humans; Intestinal Mucosa; Lactulose; Leukocyte Common Antigens; Mannitol; Multiple Sclerosis; Permeability | 1996 |
2 other study(ies) available for mannitol and Multiple Sclerosis
| Article | Year |
|---|---|
Glatiramer acetate induced acute exacerbation of autoimmune hepatitis in a patient with multiple sclerosis.
Topics: Acute Disease; Adjuvants, Immunologic; Aged; Anti-Inflammatory Agents; Antibodies, Antinuclear; Budesonide; Drug Synergism; Glatiramer Acetate; Hepatitis, Autoimmune; Humans; Iatrogenic Disease; Interferon beta-1b; Interferon-beta; Liver; Male; Mannitol; Multiple Sclerosis; Mycophenolic Acid; Peptides; Treatment Outcome | 2007 |
Acute improvement in exacerbating multiple sclerosis produced by intravenous administration of mannitol.
Topics: Adrenocorticotropic Hormone; Adult; Bicarbonates; Female; Humans; Injections, Intramuscular; Injections, Intravenous; Male; Mannitol; Middle Aged; Multiple Sclerosis; Neurologic Examination; Sodium; Sodium Bicarbonate; Sodium Chloride; Time Factors | 1985 |